[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review

August 2021 | 79 pages | ID: ED84A4E2CF3EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Eli Lilly and Co (LLY)
  • Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

    The profile contains critical company information including:
    • Business description – A detailed description of the company’s operations and business divisions.
    • Corporate strategy – Analyst’s summarization of the company’s business strategy.
    • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
    • Company history – Progression of key events associated with the company.
    • Major products and services – A list of major products, services and brands of the company.
    • Key competitors – A list of key competitors to the company.
    • Key employees – A list of the key executives of the company.
    • Executive biographies – A brief summary of the executives’ employment history.
    • Key operational heads – A list of personnel heading key departments/functions.
    • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
    • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
    • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
    Highlights

    Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human healthcare products. The company offers medicines for cardiovascular conditions, diabetes, endocrinology, cancer, neurological problems, immune disorders, men's health and musculoskeletal problems. The company distributes its pharmaceutical health products through independent wholesale distributors. It also promotes products through sales representatives and marketing agreements with other pharmaceutical companies. The company also offers its products in North America, South America, Europe, South Asia, the Middle East, Africa and North Asia-Pacific. Lilly is headquartered in Indianapolis, Indiana, the US.

    Eli Lilly and Co Key Recent Developments

    Jul 26,2021: Taoiseach opens Ireland’s largest solar farm and expansion to biotech facility
    Jul 22,2021: Menarini Asia-Pacific strengthens Men’s Health portfolio in China with acquisition of Cialis (Tadalafil) from Lilly
    Jul 16,2021: Lilly partners with Banner Alzheimer's for donanemab’s Phase III trial
    Jul 14,2021: Lilly acquires biotech firm Protomer for $1bn
    Jul 09,2021: Lilly and Verge Genomics partner to use AI for drug development

    Key benefits of buying this profile include:

    You get detailed information about the company and its operations to identify potential customers and suppliers.
    • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
    Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
    • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
    • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
    • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
    Gain key insights into the company for academic or business research.
    • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Eli Lilly and Co - Key Facts
    Eli Lilly and Co - Key Employees
    Eli Lilly and Co - Key Employee Biographies
    Eli Lilly and Co - Major Products and Services
    Eli Lilly and Co - History
    Eli Lilly and Co - Company Statement
    Eli Lilly and Co - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Joint Venture

    SECTION 2 – COMPANY ANALYSIS

    Company Overview
    Eli Lilly and Co - Business Description
    Product Category: Diabetes
    Performance
    Product Category: Immunology
    Performance
    Product Category: Neuroscience
    Performance
    Product Category: Oncology
    Performance
    Product Category: Other
    Performance
    Geographical Segment: Europe
    Performance
    Geographical Segment: Japan
    Performance
    Geographical Segment: Other Foreign Countries
    Performance
    Geographical Segment: United States
    Performance
    R&D Overview
    Eli Lilly and Co - Corporate Strategy
    Eli Lilly and Co - SWOT Analysis
    SWOT Analysis - Overview
    Eli Lilly and Co - Strengths
    Eli Lilly and Co - Weaknesses
    Eli Lilly and Co - Opportunities
    Eli Lilly and Co - Threats
    Eli Lilly and Co - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
    Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
    Eli Lilly and Co, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Jul 26, 2021: Taoiseach opens Ireland’s largest solar farm and expansion to biotech facility
    Jul 16, 2021: Lilly partners with Banner Alzheimer's for donanemab’s Phase III trial
    Jul 09, 2021: Lilly and Verge Genomics partner to use AI for drug development
    Jun 24, 2021: Lilly announces call for Leonard Award nominations as part of global initiative celebrating 100 years of insulin
    Jun 17, 2021: Lilly launches Think Talk Treat Migraine to help improve diagnosis and treatment of migraine
    May 28, 2021: US DOJ probes Eli Lilly’s Branchburg manufacturing site
    May 27, 2021: Eli Lilly and Co: Received a subpoena from the U.S. Department of Justice
    May 19, 2021: Lilly announces details of presentations at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
    May 17, 2021: Natco Pharma and Lilly sign licencing deal for baricitinib use in India
    May 05, 2021: Lilly to Participate in Bank of America Securities 2021 Health Care Conference

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Eli Lilly and Co, Key Facts
    Eli Lilly and Co, Key Employees
    Eli Lilly and Co, Key Employee Biographies
    Eli Lilly and Co, Major Products and Services
    Eli Lilly and Co, History
    Eli Lilly and Co, Subsidiaries
    Eli Lilly and Co, Joint Venture
    Eli Lilly and Co, Key Competitors
    Eli Lilly and Co, Ratios based on current share price
    Eli Lilly and Co, Annual Ratios
    Eli Lilly and Co, Annual Ratios (Cont...1)
    Eli Lilly and Co, Annual Ratios (Cont...2)
    Eli Lilly and Co, Interim Ratios
    Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
    Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
    Eli Lilly and Co, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Eli Lilly and Co, Performance Chart (2016 - 2020)
    Eli Lilly and Co, Ratio Charts
    Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
    Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


    More Publications